Oyster Point Pharma

40°40′43″N 78°14′35″W / 40.678631°N 78.243038°W / 40.678631; -78.243038

Oyster Point Pharma, Inc.
Company typeSubsidiary
Nasdaq: OYST
IndustryBiotechnology
Founded2015[1]
Headquarters
Princeton, New Jersey
,
U.S.
Key people
Jeffrey Nau (president and CEO)
Websiteoysterpointrx.com

Oyster Point Pharma, Inc. is an American biopharmaceutical company based in Princeton, New Jersey, focusing on the development of pharmaceutical therapies to treat ophthalmic diseases.[2]

  1. ^ "SEC FORM S-1". Oyster Point Pharma. Retrieved 27 April 2022.
  2. ^ "Oyster Point Pharma Inc". Reuters. Retrieved 27 April 2022.